J. Goldman & Co LP - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 65 filers reported holding NEOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$313,000
-71.5%
120,000
-82.0%
0.02%
-78.8%
Q4 2018$1,099,000
-86.4%
666,000
-59.9%
0.08%
-84.9%
Q3 2018$8,058,000
-25.0%
1,661,420
-3.3%
0.56%
+1.6%
Q2 2018$10,737,000
+4.4%
1,717,983
+38.7%
0.55%
+26.5%
Q1 2018$10,284,000
+8.6%
1,239,000
+33.5%
0.44%
-11.9%
Q4 2017$9,466,000
+62.7%
928,000
+45.9%
0.50%
+69.6%
Q3 2017$5,818,000
-5.7%
635,865
-24.7%
0.29%
-12.3%
Q2 2017$6,169,000845,0000.33%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders